A Registry of AL Amyloidosis (ReAL)
ConditionAL Amyloidosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorFondazione IRCCS Policlinico San Matteo di Pavia
About this trial
The purpose of this protocol is to generate a large registry of patients with AL amyloidosis.
Eligibility criteria
Qualifiers
diagnosis of systemic AL amyloidosis;
treatment-naïve (pre-treatment data collected at participating center available for retrospective part);
age ≥18 years;
ability to understand and willingness to sign an informed consent (patients who already sign informed consent for clinical data to be used in retrospective analyses will be accepted);
Disqualifiers
non-AL amyloidosis;
previous treatment for AL amyloidosis.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov